A fully-automated bioreactor to culture human-induced pluripotent stem cells (hiPSCs) long-term has been developed by researchers at the Fraunhofer Translational Center for Regenerative Therapies.

BETHLEHEM, Pa.--(BUSINESS WIRE)--ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform ...

Enabling quicker research, development, and production for upstream bioprocessing through scale out Like the cells they culture, bioreactors come in various shapes, sizes, and specialties. While they ...

In this interview, Dr. Marsh Durban explores how innovations such as controlled seeding and size‑selection are enabling researchers to generate uniform, assay‑ready organoids at scale.

Although bioreactor scale-up often involves matching key engineering parameters, a biology-first approach should dictate the process.

One of the most important advances in the field of cell biology came in the early 20th century, with the discovery that plant and animal cells could survive - and even replicate - outside the living ...

Human induced pluripotent stem cells (hiPSCs) are a powerful tool for innovative approaches, such as drug discovery, in vitro disease modelling, or regenerative therapies. However, such procedures ...

Designed specifically for bioreactor-scale workflows, the Krakatoa (R) K500 requires less than 15 minutes of hands-on time and produces up to 500 liters in less than three hours. Two standard pod ...